REQUEST A DEMO
Total
USD $0.00
Search more companies

Forest Pharma Sp. z o.o. (Poland)

Main Activities: All Other Food Manufacturing
Full name: Forest Pharma Sp. z o.o. Profile Updated: April 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Forest Pharma Sp. z o.o. is an enterprise in Poland, with the main office in Sliwice. The enterprise currently operates in the All Other Food Manufacturing sector. It was established on November 28, 2017. From the latest financial highlights, Forest Pharma Sp. z o.o. reported a net sales revenue increase of 3.56% in 2023. A growth of 7.43% was recorded in its total assets. The net profit margin of Forest Pharma Sp. z o.o. decreased by 26.75% in 2023.

Headquarters
Ul. Ks. Dr. Stanislawa Sychowskiego 46
Sliwice; Kujawsko-Pomorskie; Postal Code: 89-530

Contact Details: Purchase the Forest Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Forest Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Forest Pharma Sp. z o.o. report to view the information.
Incorporation Date:
November 28, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
0.04%
Purchase this report to view the information.
0.01%
Subsidiaries
Gerka Development Sp. z o.o.
50%
Company Performance
Financial values in the chart are available after Forest Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
3.56%
Total operating revenue
-24.81%
Operating profit (EBIT)
-43.06%
EBITDA
-40.91%
Net Profit (Loss) for the Period
-43.12%
Total assets
7.43%
Total equity
17.39%
Operating Profit Margin (ROS)
-29.34%
Net Profit Margin
-26.75%
Return on Equity (ROE)
-25.19%
Quick Ratio
1.89%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?